Article
Supplementation with vitamin B12 decreases homocysteine and methylmalonic acid but also serum folate in patients with end-stage renal disease.
Metabolism: clinical and experimental - 1 May 1999
Dierkes J, Domröse U, Ambrosch A, Schneede J, Guttormsen A B, Neumann K H, Luley C
Abstract excerpt
Hyperhomocysteinemia is frequently found in patients with end-stage renal disease (ESRD). Plasma total homocysteine (tHcy) concentrations may be reduced by supplementation with folic acid or combinations of folic acid, vitamin B12, and vitamin B6. Supplementation studies with vitamin B12 alone in patients with ESRD have not yet been published. In this study, we investigated the effects of intravenous injection of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
